Why Is 3D Printing Company Stratasys Stock Surging Today?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 16 2024
0mins
Source: Benzinga
Share Repurchase Program: Stratasys, Ltd. has approved a $50 million share repurchase program as part of its strategy to enhance shareholder value, following a restructuring plan aimed at saving $40 million annually by 2025.
Financial Performance: The company reported fiscal Q2 2024 revenue of $138.04 million, missing analyst estimates, while holding cash and equivalents of $150.86 million at the end of the quarter; SSYS shares rose 4.68% in premarket trading.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SSYS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SSYS
Wall Street analysts forecast SSYS stock price to rise
4 Analyst Rating
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 9.660
Low
12.00
Averages
13.17
High
14.00
Current: 9.660
Low
12.00
Averages
13.17
High
14.00
About SSYS
Stratasys Ltd. provides polymer-based 3D printing solutions for industries such as aerospace, automotive, consumer products and healthcare. The Company's solutions consist of 3D printing systems, consumables, software, paid parts, and professional services and encompass everything from prototyping and design all the way through production. Its printers include F3300, FDM Fortus 450mc, PolyJet J3 DentaJet, P3 DLP Origin One Dental, SLA Neo, PolyJet J5 Digital Anatomy, and Powder Bed Fusion SAF H350. The Company's technologies include FDM Technology, PolyJet Technology, P3 DLP Technology, SAF Technology, Stereolithography Technology and 3DFashion Technology. Its FDM 3D printing technology has the ability to use a variety of production grade thermoplastic materials featuring surface resolution, chemical and heat resistance, color, and mechanical properties necessary for production of functional prototypes and parts for a variety of industries with specific demands and requirements.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Acquisition Overview: Stratasys announced a definitive agreement to acquire MarkForged for $42.5 million in cash, expected to close in the second half of 2026, significantly strengthening its market position in high-demand manufacturing applications.
- Financial Expectations: MarkForged generated approximately $70 million in revenue in 2025, and Stratasys anticipates gross margin accretion and meaningful cost synergies within one year post-transaction, enhancing positive adjusted EBITDA contributions.
- Technological Integration Benefits: By integrating MarkForged's Continuous Carbon Fiber technology, Stratasys will provide lighter and stronger production-ready components, addressing critical industry demands in aerospace and defense, thereby enhancing its competitive edge.
- Market Network Expansion: This acquisition is set to enhance Stratasys' distribution channels and market coverage, creating additional cross-sale opportunities that will improve customer service and choice, supporting its strategic positioning in a rapidly evolving manufacturing landscape.
See More
- Acquisition Overview: Stratasys announced an all-cash acquisition of Markforged for $42.5 million, aimed at strengthening its market position in defense and aerospace, which is expected to significantly enhance the company's technological capabilities and competitive edge.
- Technology Integration Benefits: The acquisition will add Markforged's continuous carbon fiber technology and The Digital Forge software platform to Stratasys' portfolio, thereby enhancing its application capabilities across aerospace, defense, automotive, and food and beverage industries.
- Financial Expectations: Stratasys anticipates that the deal will positively impact gross margins and be accretive to EBITDA within one year of closing, while also achieving cost synergies that will further optimize financial performance.
- Market Reaction: In pre-market trading on Nasdaq, Stratasys shares rose by 2.80% to $9.93, reflecting positive market sentiment regarding the acquisition and demonstrating investor confidence in the company's future growth potential.
See More
- Acquisition Agreement: Stratasys has entered into a definitive agreement to acquire MarkForged, a wholly owned subsidiary of Nano Dimension, in an all-cash transaction valued at $42.5 million, expected to close in the second half of 2026, thereby enhancing Stratasys' capabilities in the aerospace and defense sectors.
- Revenue Contribution: MarkForged generated approximately $70 million in revenue in 2025, and while its Metal Binder Jetting product line will be retained by Nano Dimension, this acquisition will provide Stratasys with new distribution channels, enhancing its competitive position in the market.
- Positive Market Reaction: Following the announcement of the acquisition, Stratasys' stock rose by 1.9% in premarket trading, indicating investor optimism regarding the deal and its potential to bolster the company's long-term growth prospects.
- Future Guidance: Stratasys stated it would update its financial guidance following the completion of the transaction, reflecting the company's confidence in future performance and its strategic intent to expand in a rapidly evolving market landscape.
See More
- Strategic Plan Advancement: Nano Dimension has announced the sale of its wholly-owned subsidiary MarkForged for $42.5 million in cash, marking a significant step in its three-phase strategic plan aimed at maximizing long-term shareholder value through business simplification and balance sheet strengthening.
- Cash Burn Reduction: The transaction is expected to reduce annualized cash burn by approximately $15 million through a combination of direct and indirect operating cost savings, thereby enhancing the company's financial health and providing more capital for future investments.
- Product Line Retention: Despite the sale of MarkForged, Nano Dimension will retain the Markforged Metal Binder Jetting product line, a decision that not only helps maintain product diversity but also ensures competitiveness in future markets.
- Future Growth Opportunities: CEO David Stehlin stated that the transaction will accelerate the execution of Phase 3, with recent discussions held with a focused set of strategic opportunities and potential partners aimed at further enhancing shareholder value and driving long-term company growth.
See More
- Strategic Progress: Nano Dimension has announced the sale of its wholly-owned subsidiary MarkForged for $42.5 million in cash, marking a significant step in its three-phase strategic plan aimed at enhancing long-term shareholder value through business simplification and balance sheet strengthening.
- Cash Burn Reduction: The transaction is expected to reduce annualized cash burn by approximately $15 million, primarily achieved through direct and indirect operating cost savings, thereby enhancing the company's financial flexibility and supporting future growth.
- Product Line Retention: Despite the sale of MarkForged, Nano Dimension will retain the Markforged Metal Binder Jetting product line, a decision that not only ensures the continued development of core technologies but also lays the groundwork for future market opportunities.
- Future Outlook: The transaction is expected to close in the second half of 2026, as Nano Dimension continues to advance its strategic plan and actively seeks strategic opportunities with potential partners to maximize long-term shareholder value.
See More
- New Company Listing: Conexeu Sciences Inc. debuted on Nasdaq on May 21, 2026, with over 25.2 million shares issued, as CEO emphasized their CXU™ platform's goal to rebuild biological structures, potentially attracting significant investor interest in regenerative medicine.
- Significant Revenue Growth: Pacira BioSciences achieved total revenue of $726.4 million in 2025, with gross margins at a historic high of 79.4%, reflecting strong demand for its non-opioid pain therapies, which may lead to increased capital inflows into related companies.
- Bioprinting Infrastructure: Stratasys reported $237.8 million in cash and equivalents with no debt in Q1 2026, and its TrueDent® resins received CE marking, enhancing its penetration in the European market and strengthening the bioprinting industry's infrastructure.
- Wound Care Innovation: Smith & Nephew launched ALLEVYN COMPLETE CARE Foam Dressing in the U.S. in March 2026, targeting chronic wound management with robust scientific backing, addressing the growing global demand for wound care and further expanding the regenerative medicine market.
See More








